Table 2 Effect of different parameters on the enhancement time after successful intradermal injections
Enhancement time (s) Median (interquartile range) | ||||||
|---|---|---|---|---|---|---|
Parameter | Number | Antecubital fossa | Axilla | |||
Right | Left | Right | Left | |||
Sex | Males | 16 | 15 (10–31) | 20 (13–25) | 57 (31–120) | 98 (52–133) |
Females | 14 | 19 (12–25) | 12 (9–21) | 81 (42–116) | 49 (31–96) | |
p | 0.455 | 0.029 | 0.583 | 0.070 | ||
Age (years) | < 40 | 18 | 18 (11–34) | 19 (11–29) | 77 (33–123) | 92 (49–147) |
> 40 | 12 | 18 (11–25) | 15 (12–24) | 77 (32–109) | 50 (37–95) | |
p | 0.929 | 0.484 | 0.825 | 0.086 | ||
Body mass index | < 25 | 16 | 19 (13–33) | 17 (11–23) | 80 (40–123) | 69 (39–133) |
> 25 | 14 | 14 (11–25) | 14 (12–35) | 57 (28–99) | 63 (44–112) | |
p | 0.256 | 0.546 | 0.111 | 0.884 | ||
Right+ left | ||||||
Enhancement type | A | 15 + 19 = 34 | 12 (9–20) | 13 (10–19) | 36 (29–49) | 50 (32–70) |
B | 14 + 11 = 25 | 25 (18–46) | 25 (20–34) | 118 (88–134) | 126 (95–191) | |
p | 0.001 | 0.007 | 0.000 | 0.000 | ||